Request Demo
Last update 23 Jan 2025
Anhui Tiankang Pharmaceutical Co. Ltd.
Subsidiary Company|
2016|
Anhui Sheng, China
Last update 23 Jan 2025
Overview
Basic Info
Introduction Anhui Tiankang Pharmaceutical Co. Ltd. is a division of Anhui Tiankang (Group) Co., Ltd., and operates out of Tianchang, China. The company specializes in the development and production of pharmaceutical drugs. |
Tags
Neoplasms
Other Diseases
Hemic and Lymphatic Diseases
Herbal medicine
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20180254
复方黄黛片联合应用维甲酸治疗急性早幼粒细胞白血病的疗效和安全性的开放、多中心的IV期临床研究
[Translation] An open, multicenter phase IV clinical study on the efficacy and safety of Fufang Huangdai tablets combined with retinoic acid in the treatment of acute promyelocytic leukemia
CTR20170221
与单用甲磺酸伊马替尼比较，复方黄黛片联合甲磺酸伊马替尼治疗慢性粒细胞白血病的疗效和安全性III期临床研究
[Translation] Phase III clinical study on the efficacy and safety of Fufang Huangdai tablets combined with imatinib mesylate in the treatment of chronic myeloid leukemia compared with imatinib mesylate alone
CTR20160180
比较甲磺酸伊马替尼联合复方黄黛片及单一甲磺酸伊马替尼治疗慢性粒细胞白血病的疗效和安全性的III期临床研究
[Translation] Phase III clinical study comparing the efficacy and safety of imatinib mesylate combined with compound Huangdai tablets and imatinib mesylate alone in the treatment of chronic myeloid leukemia
100 Clinical Results associated with Anhui Tiankang Pharmaceutical Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Anhui Tiankang Pharmaceutical Co. Ltd.
Login to view more data
100 Translational Medicine associated with Anhui Tiankang Pharmaceutical Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 02 Feb 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free